Filed Pursuant to Rule 253(g)(2)
File No. 024-11196
SUPPLEMENT DATED MARCH 10, 2021
TO THE
OFFERING CIRCULAR DATED JULY 6, 2020
OF
CYTONICS CORPORATION
This document supplements, and should be read in conjunction with, the Offering Circular (the “Offering Circular”) dated July 6, 2020 of CYTONICS CORPORATION (the “Company”). Unless otherwise defined in this supplement, capitalized terms used in this supplement shall have the same meanings as set forth in the Offering Circular.
The Offering Circular dated July 6, 2020 is available HERE.
The purpose of this supplement is to
| · | Announce the Company’s intention to terminate the offering described in the Offering Circular on April 30, 2021, as qualified by reference to the description of the Company’s intentions below. |
Offering Termination Date
The Company intends to terminate the offering for its Series C Preferred Stock described in the Offering Circular. No further subscriptions will be accepted for the current offering after April 30, 2021 (the “Termination Date”). Subscriptions in the offering will be accepted up through that date and processed as promptly as possible. None of the terms of the offering have been changed. In addition, as described in the Offering Circular, the Company retains the right to continue the offering beyond the Termination Date, in its sole discretion.